Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
about
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsProtein kinase expression as a predictive factor for interferon response in chronic hepatitis C patientsThe treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells.The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical review.Efficacy of daclatasvir in hepatitis C virus.Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes.Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients.Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers.
P2860
Q28471847-95F3FDEC-E4D9-471C-AFF6-E10B53A0DF2FQ34961241-64C313A3-F048-48F6-AD42-091150C92C44Q35689238-EB7502F0-9308-4F93-95B8-7D3FACFD7646Q37634196-9A45F467-D0AC-4030-A741-6532A5C7407BQ38233602-11957C27-F8BB-492C-9733-A7AEFC6F2340Q42242611-3FCE3382-51E5-47F4-8BF9-ECB0EE96E102Q42979608-F381EB68-7BC3-42AC-A475-DB2AE93208DDQ47231847-97E7E6D7-FD99-4F96-A894-1E5AE2B04DC0
P2860
Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Pharmacokinetics and enhanced ...... rferon alpha-2b and ribavirin.
@en
Pharmacokinetics and enhanced ...... rferon alpha-2b and ribavirin.
@nl
type
label
Pharmacokinetics and enhanced ...... rferon alpha-2b and ribavirin.
@en
Pharmacokinetics and enhanced ...... rferon alpha-2b and ribavirin.
@nl
prefLabel
Pharmacokinetics and enhanced ...... rferon alpha-2b and ribavirin.
@en
Pharmacokinetics and enhanced ...... rferon alpha-2b and ribavirin.
@nl
P2093
P2860
P1476
Pharmacokinetics and enhanced ...... rferon alpha-2b and ribavirin.
@en
P2093
H Nakanishi
K Matsunaga
K Tsuchiya
M Kurosaki
M Uchihara
P2860
P304
P356
10.1111/J.1365-2893.2006.00803.X
P577
2007-06-01T00:00:00Z